Xbiotech says co developing true human antibody combination for influenza-covid-19 co-infections

Xbiotech developing true human antibody combination as candidate treatment for influenza-covid-19 co-infections.xbiotech inc - developing new candidate therapy called fluvid for treating illness caused by combined infections with influenza and covid-19.xbiotech inc - fluvid will contain ih201 and ih302 antibodies along with company's anti-covid-19 antibody.
XBIT Ratings Summary
XBIT Quant Ranking